back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-06-14 11:04 Tx date 2024-06-14 |
$NLII
NL2 Capital Inc. |
Dobbin, Christopher Donald
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: LIRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$110.00
+2,000 vol $0.055 each |
2,000 | |
| Filed 2024-06-14 11:04 Tx date 2022-12-28 |
$NLII
NL2 Capital Inc. |
Dobbin, Christopher Donald
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: LIRA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-06-14 11:03 Tx date 2024-06-14 |
$NLII
NL2 Capital Inc. |
Dobbin, Christopher Donald
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,245
+59,000 vol $0.055 each |
408,000 | |
| Filed 2024-06-13 07:33 Tx date 2024-06-12 |
$NLII
NL2 Capital Inc. |
Dobbin, Christopher Donald
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,000
+140,000 vol $0.05 each |
349,000 | |
| Filed 2024-05-24 20:07 Tx date 2024-05-24 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,000
+50,000 vol $0.30 each |
65,000 | |
| Filed 2024-05-23 11:13 Tx date 2024-05-22 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,182
+15,000 vol $0.3455 each |
15,000 | |
| Filed 2024-05-23 11:12 Tx date 2016-02-19 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-05-15 08:05 Tx date 2024-05-14 |
$NLII
NL2 Capital Inc. |
Dobbin, Christopher Donald
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,280
+107,000 vol $0.04 each |
209,000 | |
| Filed 2024-05-14 08:45 Tx date 2024-05-13 |
$NLII
NL2 Capital Inc. |
Dobbin, Christopher Donald
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$455.00
+13,000 vol $0.035 each |
102,000 | |
| Filed 2024-05-09 09:53 Tx date 2024-05-08 |
$NLII
NL2 Capital Inc. |
Dobbin, Christopher Donald
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,500
+30,000 vol $0.05 each |
89,000 | |
| Filed 2024-05-09 09:53 Tx date 2024-05-08 |
$NLII
NL2 Capital Inc. |
Dobbin, Christopher Donald
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,900
+19,000 vol $0.10 each |
59,000 | |
| Filed 2024-05-09 09:53 Tx date 2024-05-08 |
$NLII
NL2 Capital Inc. |
Dobbin, Christopher Donald
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,350
+30,000 vol $0.045 each |
40,000 | |
| Filed 2024-05-06 16:07 Tx date 2024-05-06 |
$NLII
NL2 Capital Inc. |
Dobbin, Christopher Donald
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$350.00
+10,000 vol $0.035 each |
10,000 | |
| Filed 2024-05-06 16:06 Tx date 2022-12-28 |
$NLII
NL2 Capital Inc. |
Dobbin, Christopher Donald
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-02 08:02 Tx date 2023-12-29 |
$NLII
NL2 Capital Inc. |
Dobbin, Christopher Donald
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$700.00
+10,000 vol $0.07 each |
2,510,000 | |
| Filed 2024-01-02 08:01 Tx date 2023-12-29 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,350
+45,000 vol $0.23 each |
8,347,858 | |
| Filed 2024-01-02 08:01 Tx date 2023-12-29 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,568
+23,200 vol $0.24 each |
8,302,858 | |
| Filed 2024-01-02 07:59 Tx date 2023-12-29 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,940
+12,000 vol $0.245 each |
8,279,658 | |
| Filed 2024-01-02 07:59 Tx date 2023-12-29 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,100
+30,000 vol $0.27 each |
8,267,658 | |
| Filed 2024-01-02 07:58 Tx date 2023-12-29 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,400
+8,000 vol $0.30 each |
8,237,658 | |
| Filed 2023-12-09 19:17 Tx date 2023-12-07 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Jill Dobbin (Indirect Ownership)
|
Options
50 - Grant of options
|
$17,500
+50,000 vol $0.35 each |
350,000 | |
| Filed 2023-12-09 19:15 Tx date 2023-12-07 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$122,499
+350,000 vol $0.35 each |
4,310,000 | |
| Filed 2023-09-13 18:23 Tx date 2023-09-13 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,500
+12,500 vol $0.20 each |
8,229,658 | |
| Filed 2023-09-13 18:23 Tx date 2023-09-13 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,312
+37,500 vol $0.195 each |
8,217,158 | |
| Filed 2023-08-15 11:58 Tx date 2023-08-15 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RESP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,060
+17,000 vol $0.18 each |
246,075 | |
| Filed 2023-06-02 12:30 Tx date 2023-06-02 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RESP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,292
+137,800 vol $0.14 each |
229,075 | |
| Filed 2023-06-01 16:03 Tx date 2023-06-01 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RESP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,120
+24,000 vol $0.13 each |
91,275 | |
| Filed 2023-05-24 11:57 Tx date 2023-05-24 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,050
+7,000 vol $0.15 each |
8,179,658 | |
| Filed 2023-03-31 17:07 Tx date 2023-03-28 |
$NLII
NL2 Capital Inc. |
Dobbin, Christopher Donald
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,250
+545,000 vol $0.05 each |
545,000 | |
| Filed 2023-03-31 17:06 Tx date 2022-12-28 |
$NLII
NL2 Capital Inc. |
Dobbin, Christopher Donald
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-31 17:05 Tx date 2023-03-28 |
$NLII
NL2 Capital Inc. |
Dobbin, Christopher Donald
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$125,000
+2,500,000 vol $0.05 each |
2,500,000 | |
| Filed 2023-03-31 13:15 Tx date 2022-12-28 |
$NLII
NL2 Capital Inc. |
Dobbin, Christopher Donald
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-18 12:02 Tx date 2022-03-30 |
$NLII
NL2 Capital Inc. |
Dobbin, Christopher Donald
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$125,000
+2,500,000 vol $0.05 each |
||
| Filed 2023-03-18 11:59 Tx date 2022-03-04 |
$NLII
NL2 Capital Inc. |
Dobbin, Christopher Donald
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-29 12:15 Tx date 2023-03-29 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,450
+45,000 vol $0.21 each |
8,172,658 | |
| Filed 2023-03-28 14:28 Tx date 2023-03-28 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,600
+30,000 vol $0.22 each |
8,127,658 | |
| Filed 2023-03-27 08:03 Tx date 2023-03-23 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$107.50
+500 vol $0.215 each |
8,097,658 | |
| Filed 2023-03-24 10:45 Tx date 2023-03-23 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RESP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,587
+6,900 vol $0.23 each |
67,275 | |
| Filed 2022-12-12 12:55 Tx date 2022-12-09 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Jill Dobbin (Indirect Ownership)
|
Options
50 - Grant of options
|
$35,000
+100,000 vol $0.35 each |
300,000 | |
| Filed 2022-12-12 12:54 Tx date 2022-12-09 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$113,750
+325,000 vol $0.35 each |
3,960,000 | |
| Filed 2022-11-24 16:05 Tx date 2022-11-24 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RESP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,860
+11,000 vol $0.26 each |
60,375 | |
| Filed 2022-11-22 16:01 Tx date 2022-11-22 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RESP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,550
+17,500 vol $0.26 each |
49,375 | |
| Filed 2022-09-30 15:09 Tx date 2022-09-30 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Jill Dobbin - RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,518
+7,300 vol $0.345 each |
43,300 | |
| Filed 2022-09-30 15:08 Tx date 2022-09-30 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Jill Dobbin - RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,179
+18,000 vol $0.3433 each |
36,000 | |
| Filed 2022-09-30 15:08 Tx date 2022-09-30 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Jill Dobbin - RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,183
+18,000 vol $0.3435 each |
18,000 | |
| Filed 2022-09-30 15:07 Tx date 2016-02-19 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Jill Dobbin - RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-09-26 16:05 Tx date 2022-09-26 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,670
+21,000 vol $0.27 each |
8,097,158 | |
| Filed 2022-09-14 14:49 Tx date 2022-09-14 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,849
+10,000 vol $0.285 each |
8,076,158 | |
| Filed 2022-09-14 12:30 Tx date 2022-09-14 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,849
+10,000 vol $0.285 each |
8,066,158 | |
| Filed 2022-09-13 16:26 Tx date 2022-09-13 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,655
+9,000 vol $0.295 each |
8,056,158 | |
| Filed 2022-09-09 11:20 Tx date 2022-09-08 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$100,000
+285,715 vol $0.35 each |
8,047,158 | |
| Filed 2022-08-16 14:19 Tx date 2022-08-16 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,160
+6,000 vol $0.36 each |
7,761,443 | |
| Filed 2022-08-16 09:41 Tx date 2022-08-16 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$875.00
+2,500 vol $0.35 each |
7,755,443 | |
| Filed 2022-08-16 09:41 Tx date 2022-08-16 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,700
+5,000 vol $0.34 each |
7,752,943 | |
| Filed 2022-08-16 09:40 Tx date 2022-08-16 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,155
+3,500 vol $0.33 each |
7,747,943 | |
| Filed 2022-06-30 15:37 Tx date 2022-06-30 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,687
+12,500 vol $0.375 each |
7,744,443 | |
| Filed 2022-06-30 13:54 Tx date 2022-06-30 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$962.50
+2,500 vol $0.385 each |
7,731,943 | |
| Filed 2022-06-30 13:54 Tx date 2022-06-30 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$950.00
+2,500 vol $0.38 each |
7,729,443 | |
| Filed 2022-06-30 09:47 Tx date 2022-06-30 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,470
+6,500 vol $0.38 each |
7,726,943 | |
| Filed 2022-06-29 09:49 Tx date 2022-06-29 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$950.00
+2,500 vol $0.38 each |
7,720,443 | |
| Filed 2022-06-28 14:52 Tx date 2022-06-28 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,900
+5,000 vol $0.38 each |
7,717,943 | |
| Filed 2022-06-28 12:55 Tx date 2022-06-28 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,835
+7,000 vol $0.405 each |
7,712,943 | |
| Filed 2022-06-15 15:18 Tx date 2022-06-15 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$937.50
+2,500 vol $0.375 each |
7,705,943 | |
| Filed 2022-06-15 14:17 Tx date 2022-06-15 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$950.00
+2,500 vol $0.38 each |
7,703,443 | |
| Filed 2022-06-15 10:02 Tx date 2022-06-15 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$962.50
+2,500 vol $0.385 each |
7,700,943 | |
| Filed 2022-06-14 16:03 Tx date 2022-06-14 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$770.00
+2,000 vol $0.385 each |
7,698,443 | |
| Filed 2022-06-14 11:46 Tx date 2022-06-14 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$975.00
+2,500 vol $0.39 each |
7,696,443 | |
| Filed 2022-06-13 10:23 Tx date 2022-06-13 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$900.00
+2,500 vol $0.36 each |
7,693,943 | |
| Filed 2022-06-13 10:14 Tx date 2022-06-13 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$912.50
+2,500 vol $0.365 each |
7,691,443 | |
| Filed 2022-06-10 14:43 Tx date 2022-06-10 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$993.75
+2,500 vol $0.3975 each |
7,688,943 | |
| Filed 2022-06-08 14:55 Tx date 2022-06-08 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,900
+10,000 vol $0.39 each |
7,686,443 | |
| Filed 2022-06-08 14:37 Tx date 2022-06-08 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$992.50
+2,500 vol $0.397 each |
7,676,443 | |
| Filed 2022-06-06 15:46 Tx date 2022-06-06 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,250
+10,000 vol $0.425 each |
7,673,943 | |
| Filed 2022-06-03 16:01 Tx date 2022-06-03 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,740
+4,000 vol $0.435 each |
7,663,943 | |
| Filed 2022-06-03 11:30 Tx date 2022-06-03 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,125
+2,500 vol $0.45 each |
7,659,943 | |
| Filed 2022-05-27 15:58 Tx date 2022-05-27 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,305
+10,500 vol $0.41 each |
7,657,443 | |
| Filed 2022-05-27 15:25 Tx date 2022-05-27 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RESP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,600
+4,000 vol $0.40 each |
31,875 | |
| Filed 2021-12-30 16:19 Tx date 2021-12-30 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RESP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,900
+16,500 vol $0.60 each |
27,875 | |
| Filed 2021-12-24 12:38 Tx date 2021-12-24 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,100
+10,000 vol $0.61 each |
7,646,943 | |
| Filed 2021-12-24 12:36 Tx date 2021-12-24 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,200
+10,000 vol $0.62 each |
7,636,943 | |
| Filed 2021-12-22 12:28 Tx date 2021-12-21 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Jill Dobbin (Indirect Ownership)
|
Options
50 - Grant of options
|
$58,500
+75,000 vol $0.78 each |
200,000 | |
| Filed 2021-12-22 12:26 Tx date 2021-12-21 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$253,500
+325,000 vol $0.78 each |
3,635,000 | |
| Filed 2021-12-13 13:09 Tx date 2021-12-13 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,240
+4,000 vol $0.56 each |
7,626,943 | |
| Filed 2021-12-09 14:07 Tx date 2021-12-09 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,265
+10,500 vol $0.60 each |
7,622,943 | |
| Filed 2021-11-25 15:10 Tx date 2021-11-25 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,875
+7,500 vol $0.65 each |
7,612,443 | |
| Filed 2021-08-16 12:35 Tx date 2021-08-16 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RESP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,822
+11,375 vol $0.78 each |
11,375 | |
| Filed 2021-08-16 12:34 Tx date 2016-02-19 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RESP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-08-10 09:59 Tx date 2021-08-10 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,545
+11,500 vol $0.83 each |
7,604,943 | |
| Filed 2021-06-11 17:33 Tx date 2021-06-11 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$12,080
+16,778 vol $0.72 each |
7,593,443 | |
| Filed 2021-01-05 19:09 Tx date 2020-12-31 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$1,559,775
+2,079,700 vol $0.75 each |
7,576,665 | |
| Filed 2021-01-05 19:07 Tx date 2020-12-31 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$-1,559,775
-2,079,700 vol $0.75 each |
0 | |
| Filed 2020-12-30 10:25 Tx date 2020-12-30 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$253,500
+325,000 vol $0.78 each |
3,310,000 | |
| Filed 2020-02-24 18:21 Tx date 2020-02-22 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Warrants
55 - Expiration of warrants
|
$-93,750
-250,000 vol $0.375 each |
0 | |
| Filed 2019-12-31 11:45 Tx date 2019-12-31 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$97,562
+278,750 vol $0.35 each |
5,496,965 | |
| Filed 2019-12-31 11:43 Tx date 2019-12-31 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-97,562.50
-278,750 vol $0.35 each |
250,000 | |
| Filed 2019-12-13 19:11 Tx date 2019-12-10 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Jill Dobbin (Indirect Ownership)
|
Options
50 - Grant of options
|
$33,750
+75,000 vol $0.45 each |
125,000 | |
| Filed 2019-12-13 19:09 Tx date 2019-12-10 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$315,000
+700,000 vol $0.45 each |
2,985,000 | |
| Filed 2019-10-05 16:47 Tx date 2019-10-05 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Warrants
55 - Expiration of warrants
|
$-175,000
-500,000 vol $0.35 each |
528,750 | |
| Filed 2019-10-05 16:45 Tx date 2019-07-05 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Warrants
55 - Expiration of warrants
|
$-140,624.75
-401,785 vol $0.35 each |
1,028,750 | |
| Filed 2019-06-28 11:12 Tx date 2019-06-28 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,425
+15,000 vol $0.295 each |
2,079,700 | |
| Filed 2019-01-21 Tx date 2019-01-21 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-87,500
-250,000 vol $0.35 each |
1,466,250 | |
| Filed 2019-01-21 Tx date 2016-02-19 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Jill Dobbin (Control or Direction)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-21 Tx date 2019-01-14 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Jill Dobbin (Control or Direction)
|
Options
50 - Grant of options
|
$22,500
+50,000 vol $0.45 each |
50,000 | |
| Filed 2019-01-21 Tx date 2019-01-21 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$100,000
+285,715 vol $0.35 each |
5,218,215 | |
| Filed 2019-01-21 Tx date 2019-01-21 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-12,500.25
-35,715 vol $0.35 each |
1,430,535 | |
| Filed 2019-01-15 Tx date 2019-01-14 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$450,000
+1,000,000 vol $0.45 each |
2,285,000 | |
| Filed 2018-12-18 Tx date 2018-12-18 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,900
+13,000 vol $0.30 each |
2,064,700 | |
| Filed 2018-12-10 Tx date 2018-12-10 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$990.00
+3,000 vol $0.33 each |
2,051,700 | |
| Filed 2018-11-30 Tx date 2018-11-30 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,218
+4,200 vol $0.29 each |
2,048,700 | |
| Filed 2018-09-17 Tx date 2018-09-13 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,127
+8,500 vol $0.3679 each |
2,042,500 | |
| Filed 2018-09-17 Tx date 2018-09-14 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$695.00
+2,000 vol $0.3475 each |
2,044,500 | |
| Filed 2018-05-31 Tx date 2018-05-31 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$450,000
+1,500,000 vol $0.30 each |
4,932,500 | |
| Filed 2018-02-24 Tx date 2018-02-23 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Warrants
11 - Acquisition or disposition carried out privately
|
$93,750
+250,000 vol $0.375 each |
1,716,250 | |
| Filed 2018-02-24 Tx date 2018-02-23 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$125,000
+500,000 vol $0.25 each |
3,432,500 | |
| Filed 2018-01-12 Tx date 2018-01-12 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$200,000
+800,000 vol $0.25 each |
1,285,000 | |
| Filed 2018-01-10 Tx date 2018-01-08 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$97,562
+278,750 vol $0.35 each |
1,466,250 | |
| Filed 2018-01-10 Tx date 2018-01-08 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$111,500
+557,500 vol $0.20 each |
2,932,500 | |
| Filed 2017-10-16 Tx date 2017-10-16 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,997
+8,500 vol $0.235 each |
2,034,000 | |
| Filed 2017-10-07 Tx date 2017-10-06 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$175,000
+500,000 vol $0.35 each |
1,187,500 | |
| Filed 2017-10-07 Tx date 2017-10-06 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$200,000
+1,000,000 vol $0.20 each |
2,375,000 | |
| Filed 2017-09-18 Tx date 2017-09-14 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$360.00
+1,500 vol $0.24 each |
2,025,500 | |
| Filed 2017-07-15 Tx date 2017-07-11 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$450.00
+1,500 vol $0.30 each |
2,006,000 | |
| Filed 2017-07-15 Tx date 2017-07-12 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$885.00
+3,000 vol $0.295 each |
2,024,000 | |
| Filed 2017-07-15 Tx date 2017-07-12 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,500
+5,000 vol $0.30 each |
2,021,000 | |
| Filed 2017-07-15 Tx date 2017-07-12 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,900
+10,000 vol $0.29 each |
2,016,000 | |
| Filed 2017-07-10 Tx date 2017-07-07 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$175,000
+875,000 vol $0.20 each |
||
| Filed 2017-07-10 Tx date 2017-07-07 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+437,500 vol |
||
| Filed 2017-07-10 Tx date 2017-07-06 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+437,500 vol |
687,500 | |
| Filed 2017-07-10 Tx date 2017-07-06 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$175,000
+875,000 vol $0.20 each |
1,375,000 | |
| Filed 2017-06-01 Tx date 2017-05-31 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Convertible Debentures 7.5% convertible into Common shares
38 - Redemption, retraction, cancellation, repurchase
|
-$75,000 vol |
$0 | |
| Filed 2017-03-13 Tx date 2017-03-10 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$100,000
+500,000 vol $0.20 each |
500,000 | |
| Filed 2017-03-13 Tx date 2017-03-10 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$87,500
+250,000 vol $0.35 each |
250,000 | |
| Filed 2017-03-13 Tx date 2016-02-19 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-13 Tx date 2016-02-19 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-28 Tx date 2016-12-23 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$945.00
+4,500 vol $0.21 each |
2,004,500 | |
| Filed 2016-11-01 Tx date 2016-02-19 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Convertible Debentures 7.5% Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-11-01 Tx date 2016-10-28 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Holder: Precipice Holdings Limited (Indirect Ownership)
|
Convertible Debentures 7.5% convertible into Common shares
11 - Acquisition or disposition carried out privately
|
$
+$75,000 vol $0.20 each |
$75,000 | |
| Filed 2016-04-28 Tx date 2016-02-19 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-04-28 Tx date 2016-04-26 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$48,500
+485,000 vol $0.10 each |
485,000 | |
| Filed 2016-02-22 Tx date 2016-02-19 |
$NLH
Nova Leap Health Corp. |
Dobbin, Christopher Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,000,000 |